Boost your portfolio with these fantastic buy-rated ASX 200 stocks

There are plenty of quality options for investors on the ASX 200 index. So many, it can be hard to decide which ones to buy over others.

But don’t worry if you are paralysed by choice, because I’m going to try and narrow things down by picking out two high-quality ASX 200 stocks that analysts rate highly.

They are as follows:

CSL Limited (ASX: CSL)

This biotherapeutics company could be an ASX 200 stock to buy. That’s the view of analysts at Morgans, which think very highly of the company.

Morgans believes CSL’s outlook is very positive after COVID headwinds ended and tailwinds took over. In addition, the broker feels that CSL’s shares are trading at a “good value” for investors. It explains:

A key portfolio holding and key sector pick, we believe CSL is poised to break-out this year, a COVID exit trade, offering double-digit recovery in earnings growth as plasma collections increase, new products get approved and influenza vaccine uptake increases around ongoing concerns about respiratory viruses, with shares offering good value trading around its long-term forward multiple of ~30x.

Morgans has an add rating and $337.92 price target on CSL’s shares.

Nextdc Ltd (ASX: NXT)

Another ASX 200 stock that brokers are bullish on is data centre operator NextDC.

Goldman Sachs is among its fans, with its analysts believing the company is well-placed to benefit from the rapid growth in cloud adoption. It notes that this is underpinning significant demand from both public and private markets. It commented:

NextDC is an Australian based Data Centre operator. We are particularly positive on NXT and are Buy rated given the rapid growth in cloud adoption, which has been supported by the continued evolution of the enterprise telecommunications market, and the significant demand by both public and private investors for digital infrastructure assets. We believe the company has a compelling growth profile and a proven and profitable business model, noting it trades on a growth-adjusted discount vs. peers, which we view as unjustified.

Goldman has a buy rating and $14.96 price target on NextDC’s shares.